Clinical Trials
6
Trial Phases
3 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (6 trials with phase data)• Click on a phase to view related trials
Study of the Safety, Tolerability, Pharmacokinetics of NIOCH-14 in Volunteers Aged 18-50 Years
- Conditions
- SmallpoxMonkeypoxVaccinia Virus InfectionCowpox
- First Posted Date
- 2023-08-04
- Last Posted Date
- 2023-08-04
- Lead Sponsor
- Federal Budgetary Research Institution State Research Center of Virology and Biotechnology "Vector"
- Target Recruit Count
- 90
- Registration Number
- NCT05976100
- Locations
- 🇷🇺
Federal State Budgetary Healthcare Institution - Medical and Sanitary Unit No. 163 of the Federal Medical and Biological Agency (FGBUZ MSCH-163, FMBA Russia), Novosibirsk, Koltsovo, Novosibirsk Region, Russian Federation
Study on Immunogenicity, Reactogenicity and Safety of the VACΔ6 Vaccine in Volunteers Aged 18-60 Years
- Conditions
- CowpoxVaccinia Virus InfectionMonkeypoxSmallpox
- First Posted Date
- 2023-05-06
- Last Posted Date
- 2023-05-06
- Lead Sponsor
- Federal Budgetary Research Institution State Research Center of Virology and Biotechnology "Vector"
- Target Recruit Count
- 334
- Registration Number
- NCT05846243
- Locations
- 🇷🇺
Federal State Budgetary Institution of Healthcare "Medical and Sanitary Unit No. 163 of the Federal Medical and Biological Agency" (FGBUZ MSCH-163, FMBA of Russia), Koltsovo, Novosibirsk Region, Russian Federation
🇷🇺State Budgetary Health Institution of the Novosibirsk Region "Municipal Infectious Disease Clinical Hospital No. 1", Novosibirsk, Russian Federation
Safety and Tolerability Study of the VAC∆6 Vaccine in Volunteers Aged 18-40 Years
- Conditions
- Vaccinia Virus InfectionMonkeypoxSmallpoxCowpox
- First Posted Date
- 2023-03-09
- Last Posted Date
- 2023-03-09
- Lead Sponsor
- Federal Budgetary Research Institution State Research Center of Virology and Biotechnology "Vector"
- Target Recruit Count
- 60
- Registration Number
- NCT05762523
- Locations
- 🇷🇺
Federal State Budgetary Healthcare Institution - Medical and Sanitary Unit No. 163 of the Federal Medical and Biological Agency (FGBUZ MSCH-163, FMBA Russia), Novosibirsk, Koltsovo, Novosibirsk Region, Russian Federation
Study of the EpiVacCorona Vaccine With the Involvement of Volunteers Aged 60 Years and Above
- Conditions
- Covid19
- First Posted Date
- 2021-08-25
- Last Posted Date
- 2021-08-27
- Lead Sponsor
- Federal Budgetary Research Institution State Research Center of Virology and Biotechnology "Vector"
- Target Recruit Count
- 150
- Registration Number
- NCT05021016
- Locations
- 🇷🇺
Federal State Budgetary Institution of Healthcare "Medical and Sanitary Unit No. 163 of the Federal Medical and Biological Agency" (FGBUZ MSCH-163, FMBA of Russia), Kol'tsovo, Novosibirsk Region, Russian Federation
Study of the Tolerability, Safety, Immunogenicity and Preventive Efficacy of the EpiVacCorona Vaccine for the Prevention of COVID-19
- Conditions
- COVID-19
- First Posted Date
- 2021-03-03
- Last Posted Date
- 2022-03-16
- Lead Sponsor
- Federal Budgetary Research Institution State Research Center of Virology and Biotechnology "Vector"
- Target Recruit Count
- 3000
- Registration Number
- NCT04780035
- Locations
- 🇷🇺
State Budgetary Healthcare Institution of the Moscow region - Krasnogorsk City Hospital # 1 (short name: SBHI MR KCH # 1), Krasnogorsk, Moscow Region, Russian Federation
🇷🇺Federal State Autonomous Educational Institution of Higher Education - Immanuel Kant Baltic University (short name: FSAEIHE- I. Kant Baltic Federal University), Kaliningrad, Russian Federation
🇷🇺State Autonomous Healthcare Institution - Clinical City Hospital # 7 of Kazan (short name: SAHI CCH # 7), Kazan, Russian Federation
- Prev
- 1
- 2
- Next